NNNN Anbio Biotechnology: Prakiraan wutah bathi kanggo taun ngarep
Anbio Biotechnology is developing decentralized diagnostics through current POCT solutions. The projected EPS growth rate clearly demonstrates the asset's market position, where 0.00 represents the latest level value. Strategic alliances with clinics are expanding test distribution, although regulatory barriers and the post-pandemic decline in demand create certain risks for the pace of business expansion.
NNNN (anbio.com): rincian analitis lan laporan miturut indikator
- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- indikator kapitalisasi buku:
- rincian utang lan likuiditas:
Total Utang marang Modal Anbio Biotechnology|NNNN - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Anbio|NNNN - Utang kumulatif perusahaan|Utang marang nilai buku Anbio Biotechnology|NNNN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Anbio Biotechnology|Rasio cepet anbio.com
- data bathi resik lan rasio valuasi:
NNNN - Asil keuangan resik|Bathi sing dikarepake Anbio Biotechnology|NNNN - Kapitalisasi marang bathi|Prakiraan rega marang bathi Anbio Biotechnology|NNNN - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Anbio Biotechnology|NNNN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Anbio Biotechnology|NNNN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan anbio.com|NNNN - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Anbio Biotechnology
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:Anbio Tech
This indicator reflects the analysts' consensus forecast for earnings per share changes, allowing for an assessment of the asset's fundamental value between reporting periods. By analyzing the trend of market expectations for EPS growth, an investor can determine the scaling potential of Anbio Biotechnology through expansion into the home diagnostics segment and the miniaturization of portable analyzers for the global in-vitro market.
Analisis pesaing Anbio Biotechnology
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|Prakiraan wutah bathi kanggo taun ngarep exactsciences.com (EXAS)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Revvity RVTY|BIO: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Sterigenics - Prakiraan wutah bathi kanggo taun ngarep|QDEL: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|OPK: Prakiraan wutah bathi kanggo taun ngarep|CDNA - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Maravai LifeSciences Holdings, Inc.|Prakiraan wutah bathi resik saben saham ing taun ngarep Fulgent Genetics Inc FLGT|Prakiraan wutah bathi saben saham kanggo taun ngarep LAB (Fluidigm)|CTKB (Cytek Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OSUR (OraSure Technologies)|Exagen Inc - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MDxHealth - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lucid Diagnostics, Inc. LUCD|prenetics.com (PRE) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Insight Molecular Diagnostics Inc (IMDX)|Prakiraan wutah bathi saben saham kanggo taun ngarep TRIB|PRPH (prophaselabs.com) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep AIMD|CODX - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep HSCS (Heart Test Laboratories Inc.)|BMRA - Prakiraan wutah bathi saben saham kanggo taun ngarep|Cardio Diagnostics Holdings, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep ONCO (onconetix.gcs-web.com)|Virax Biolabs (VRAX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep BJDX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Vermillion|Prakiraan wutah bathi resik saben saham ing taun ngarep Accelerate Diagnostics Inc AXDX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centogene NV (CNTG)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ENZ (enzo.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fresh2 Group FRES|Genetic Technologies Ltd (GENE) - Prakiraan wutah bathi resik saben saham ing taun ngarep|23andMe Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Psychemedics Inc (PMD)
